Subsequent histo-morphological and immunohistochemistry (IHC) findings (Table 2) and NGS sarcoma panel from MedGenome were suggestive of a diagnosis of RMS with positive oncogenic fusion of FUS-TFCP2. The gene discussed is TFCP2; the disease is sarcoma.